截至4月29日,医疗服务行业已有39家公司披露2025年一季报,其中诺泰生物、睿智医药、昭衍新药、光正眼科和成都先导五家公司的净利润实现翻倍。诺泰生物一季度营收5.66亿元,同比增长58.96%,净利润1.53亿元,同比增长130.1%;睿智医药一季度营收2.61亿元,同比增长11.37%,成功扭亏为盈,净利润664.21万元;昭衍新药一季度营收2.87亿元,同比下降11.54%,但净利润...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.